Subtype
Brain Neoplasm
CI-CAN-00002030Explore in graph →
Non-malignant512 active trials34 evidence items
Loading cancer entity…
Subtype
CI-CAN-00002030Explore in graph →
Clinical trials
2,118 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02575521 | Effect of Propofol-Dexmedetomidine on Cerebral Oxygenation and Metabolism During Brain Tumor Resection | completed | N/A | 50 | Mansoura UniversityOTHER | 0 | Nov 8, 2017 | clinicaltrials |
| NCT02006563 | Metabolic Tumor Volumes in Radiation Treatment of Primary Brain Tumors | completed | — | 22 | University of MiamiOTHER | 1 | Oct 24, 2017 | clinicaltrials |
| NCT00045708 |
| A Phase I/II Trial of BMS-247550 for Treatment of Patients With Recurrent High-Grade Gliomas |
| completed |
| Phase 1 / Phase 2 |
| 57 |
| National Cancer Institute (NCI)NIH |
| 1 |
| Oct 18, 2017 |
| clinicaltrials |
| NCT02306278 | The Effects of Gabapentin Premedication on Neurosurgery | completed | N/A | 122 | Capital Medical UniversityOTHER | 1 | Oct 16, 2017 | clinicaltrials |
| NCT00946673 | Phase I Vorinostat Concurrent With Stereotactic Radiosurgery (SRS) in Brain Metastases From Non-Small Cell Lung Cancer | completed | Phase 1 | 17 | Stanford UniversityOTHER | 1 | Oct 6, 2017 | clinicaltrials |
| NCT03271918 | Cabergoline in Nonfunctioning Pituitary Adenomas | completed | Phase 3 | 140 | University of Sao Paulo General HospitalOTHER | 1 | Sep 7, 2017 | clinicaltrials |
| NCT02452216 | Using Ferumoxytol-Enhanced MRI to Measure Inflammation in Patients With Brain Tumors or Other Conditions of the CNS | completed | Early Phase 1 | 10 | Michael IvOTHER | 1 | Aug 31, 2017 | clinicaltrials |
| NCT02058745 | SmartCare: Innovations in Caregiving Interventions(SmartCare) | completed | N/A | 240 | University of PittsburghOTHER | 1 | Aug 29, 2017 | clinicaltrials |
| NCT00522951 | SH L 562BB Phase II/III Dose Justification and Gadoteridol-controlled Comparative Study | completed | Phase 3 | 165 | BayerINDUSTRY | 1 | Aug 28, 2017 | clinicaltrials |
| NCT00003475 | Antineoplaston Therapy in Treating Patients With Primary Malignant Brain Tumors | completed | Phase 2 | 40 | Burzynski Research InstituteOTHER | 1 | Aug 24, 2017 | clinicaltrials |
| NCT00003537 | Antineoplaston Therapy in Treating Adult Patients With Anaplastic Astrocytoma(AA) | completed | Phase 2 | 19 | Burzynski Research InstituteOTHER | 1 | Aug 24, 2017 | clinicaltrials |
| NCT00003457 | Antineoplaston Therapy in Treating Patients With Brain Tumors | completed | Phase 2 | 40 | Burzynski Research InstituteOTHER | 1 | Aug 22, 2017 | clinicaltrials |
| NCT00045110 | Erlotinib in Treating Patients With Recurrent Malignant Glioma or Recurrent or Progressive Meningioma | completed | Phase 1 / Phase 2 | 136 | National Cancer Institute (NCI)NIH | 1 | Aug 17, 2017 | clinicaltrials |
| NCT00980343 | GDC-0449 in Treating Patients With Recurrent Glioblastoma Multiforme That Can Be Removed by Surgery | completed | Phase 2 | 44 | National Cancer Institute (NCI)NIH | 1 | Aug 16, 2017 | clinicaltrials |
| NCT00540722 | Gossypol in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme | completed | Phase 2 | 56 | National Cancer Institute (NCI)NIH | 1 | Aug 11, 2017 | clinicaltrials |
| NCT01708174 | A Phase II Study of Oral LDE225 in Patients With Hedge-Hog (Hh)-Pathway Activated Relapsed Medulloblastoma (MB) | completed | Phase 2 | 22 | Novartis PharmaceuticalsINDUSTRY | 13 | Aug 11, 2017 | clinicaltrials |
| NCT01801813 | Risk Factors of Complications Regarding Patients Undergoing Brain Tumour Neuro-surgery (Cranioscore).(Cranioscore) | completed | — | 795 | Nantes University HospitalOTHER | 1 | Aug 11, 2017 | clinicaltrials |
| NCT01975116 | p28 in Treating Younger Patients With Recurrent or Progressive Central Nervous System Tumors | completed | Phase 1 | 18 | Pediatric Brain Tumor ConsortiumNETWORK | 1 | Aug 7, 2017 | clinicaltrials |
| NCT01276210 | Sorafenib Tosylate and Stereotactic Radiosurgery in Treating Patients With Brain Metastases | completed | Phase 1 | 23 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Jul 17, 2017 | clinicaltrials |
| NCT00823797 | Bendamustine Hydrochloride in Treating Patients With Recurrent or Progressive Anaplastic Glioma | completed | Phase 2 | 45 | University of WashingtonOTHER | 1 | Jul 7, 2017 | clinicaltrials |
| NCT00001328 | Gene Therapy for the Treatment of Brain Tumors | completed | Phase 1 | 15 | National Institute of Neurological Disorders and Stroke (NINDS)NIH | 1 | Jul 2, 2017 | clinicaltrials |
| NCT00923468 | Pharmacokinetic Studies Participation Survey | completed | — | 25 | National Cancer Institute (NCI)NIH | 1 | Jul 2, 2017 | clinicaltrials |
| NCT00923650 | Informed Consent in Pediatric Cancer Trials | completed | — | 1 | National Cancer Institute (NCI)NIH | 1 | Jul 2, 2017 | clinicaltrials |
| NCT00362817 | Carboplatin and Temozolomide (Temodar) for Recurrent and Symptomatic Residual Brain Metastases | completed | Phase 1 / Phase 2 | 17 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Jun 1, 2017 | clinicaltrials |
| NCT00576472 | Learning Impairments Among Survivors of Childhood Cancer | completed | Phase 4 | 469 | St. Jude Children's Research HospitalOTHER | 1 | May 30, 2017 | clinicaltrials |
| NCT00595322 | Bevacizumab in the Radiation Treatment of Recurrent Malignant Glioma | completed | N/A | 25 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | May 23, 2017 | clinicaltrials |
| NCT00724737 | Presurgical Planning With Functional MRI (fMRI) Mapping of Motor Cortex in Patients With Cerebral Tumors | completed | N/A | 23 | University of MichiganOTHER | 1 | May 18, 2017 | clinicaltrials |
| NCT00660543 | MRI Study With Ferumoxytol in Assessing Early Response in Patients With Glioblastoma Multiforme Receiving Temozolomide and Radiation Therapy | completed | N/A | 14 | OHSU Knight Cancer InstituteOTHER | 1 | May 16, 2017 | clinicaltrials |
| NCT01288573 | A Combined Study in Pediatric Cancer Patients for Dose Ranging and Efficacy/Safety of Plerixafor Plus Standard Regimens for Mobilization Versus Standard Regimens Alone | completed | Phase 1 / Phase 2 | 46 | Genzyme, a Sanofi CompanyINDUSTRY | 12 | May 16, 2017 | clinicaltrials |
| NCT00045734 | Imatinib Mesylate in Treating Patients With Recurrent Meningioma | completed | Phase 2 | 23 | National Cancer Institute (NCI)NIH | 1 | May 15, 2017 | clinicaltrials |
| NCT00076856 | Temozolomide for Treatment of Brain Metastases From Non-Small Cell Lung Cancer (Study P03247) | completed | Phase 2 | 95 | Merck Sharp & Dohme LLCINDUSTRY | 0 | May 9, 2017 | clinicaltrials |
| NCT01707836 | Neurofibromatosis Type 1 Brain Tumor Genetic Risk | completed | — | 176 | Washington University School of MedicineOTHER | 1 | May 9, 2017 | clinicaltrials |
| NCT03137615 | The Cardiovascular Changes Associated With Septal Local Anaesthesia | completed | — | 15 | Sheffield Teaching Hospitals NHS Foundation TrustOTHER | 0 | May 3, 2017 | clinicaltrials |
| NCT01393912 | PDGFR Inhibitor Crenolanib in Children/Young Adults With Diffuse Intrinsic Pontine Glioma or Recurrent High-Grade Glioma | completed | Phase 1 | 55 | St. Jude Children's Research HospitalOTHER | 1 | Apr 26, 2017 | clinicaltrials |
| NCT00693914 | Working Memory Performance Among Childhood Brain Tumor Survivors | completed | — | 130 | St. Jude Children's Research HospitalOTHER | 1 | Apr 25, 2017 | clinicaltrials |
| NCT02208336 | Electronic Medical Record Review in Monitoring the Effects of Adherence on Myelosuppression and Morbidity in Patients With Newly Diagnosed Brain Tumors Receiving Temozolomide and Radiation Therapy | completed | — | 79 | Wake Forest University Health SciencesOTHER | 1 | Apr 19, 2017 | clinicaltrials |
| NCT00706810 | Combination of Hydroxyurea and Verapamil for Refractory Meningiomas | completed | Phase 2 | 8 | University of UtahOTHER | 1 | Apr 13, 2017 | clinicaltrials |
| NCT00379080 | Tandutinib in Treating Patients With Recurrent or Progressive Glioblastoma | completed | Phase 1 / Phase 2 | 60 | National Cancer Institute (NCI)NIH | 1 | Apr 7, 2017 | clinicaltrials |
| NCT00201903 | The Roles of Tissue Factor in Malignant Gliomas | completed | — | 30 | Ontario Clinical Oncology Group (OCOG)OTHER | 2 | Apr 6, 2017 | clinicaltrials |
| NCT01125800 | A Phase I Dose Finding and Safety Study of Oral LDE225 in Children and a Phase II Portion to Assess Preliminary Efficacy in Recurrent or Refractory MB | completed | Phase 1 / Phase 2 | 76 | Novartis PharmaceuticalsINDUSTRY | 6 | Mar 20, 2017 | clinicaltrials |
| NCT00459381 | Pazopanib in Treating Patients With Recurrent Glioblastoma | completed | Phase 2 | 35 | National Cancer Institute (NCI)NIH | 1 | Mar 15, 2017 | clinicaltrials |
| NCT00185848 | Assessing the Suitability of an Imaging Probe for Use in Clinical Cell and Gene Therapy Trials in Cancer and Rheumatoid Arthritis | completed | Phase 1 | 10 | Sanjiv Sam GambhirOTHER | 1 | Mar 14, 2017 | clinicaltrials |
| NCT02809651 | Confounding Factors in the Detection of Intracranial Hemorrhage With the Infrascanner | completed | N/A | 89 | Ziekenhuis Oost-LimburgOTHER | 1 | Mar 14, 2017 | clinicaltrials |
| NCT01738646 | Ph II SAHA and Bevacizumab for Recurrent Malignant Glioma Patients | completed | Phase 2 | 48 | Duke UniversityOTHER | 1 | Mar 6, 2017 | clinicaltrials |
| NCT01484873 | Weight Loss Study for Patients With Obesity Due to Craniopharyngioma or Other Brain Tumor | completed | Phase 2 | 10 | Vanderbilt University Medical CenterOTHER | 1 | Mar 3, 2017 | clinicaltrials |
| NCT01724801 | Icotinib or Whole Brain Irradiation in EGFR-mutant Lung Cancer(BRAIN) | completed | Phase 3 | 176 | Guangdong Association of Clinical TrialsOTHER | 1 | Mar 1, 2017 | clinicaltrials |
| NCT01250470 | Vaccine Therapy and Sargramostim in Treating Patients With Malignant Glioma | completed | Phase 1 | 9 | Roswell Park Cancer InstituteOTHER | 1 | Feb 27, 2017 | clinicaltrials |
| NCT02311556 | Response of Brain Metastases After Gamma-Knife Radiosurgery Using Dynamic Susceptibility-weighted Contrast-enhanced Perfusion Magnetic Resonance Imaging | completed | Phase 1 | 23 | Washington University School of MedicineOTHER | 1 | Feb 24, 2017 | clinicaltrials |
| NCT00207350 | Neurosurgical Use of Interstitial Laser Therapy (ILT)(ILT) | completed | N/A | 6 | Brigham and Women's HospitalOTHER | 1 | Feb 23, 2017 | clinicaltrials |
| NCT01881854 | Sleep Wake and Melatonin Pattern in Craniopharyngioma | completed | — | 30 | Rigshospitalet, DenmarkOTHER | 0 | Feb 23, 2017 | clinicaltrials |
Data updated 23 days agoSource updated Nov 8, 2017source: clinicaltrials